Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

TuHURA Biosciences, Inc.

NASDAQ: HURA · Life Sciences · 8 alerts · CIK 1498382

Share price
$1.33Close, Nov 16
Market cap
$87.5M
Shares outstanding
65.76MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All TuHURA Biosciences, Inc. filings on SEC EDGAR ↗

5:00 PM ET 8-K
Loan & Debt

TuHURA Biosciences $50M Debt Financing with Parkview Holdings One LLC

TuHURA Biosciences borrowed an additional $1.5 million under its existing revolving credit facility with Parkview Holdings One LLC. The facility, which matures in April 2031, has a maximum loan availability of $50 million. The company intends to use the proceeds for general corporate purposes.

Value
$50M
Counterparty
Parkview Holdings One LLC
Term
through April 2031
5:00 PM ET 8-K
Loan & Debt

TuHURA Biosciences $50M Debt Financing with Parkview Holdings One LLC

TuHURA Biosciences received and borrowed an additional $650,000 draw under its existing $50 million revolving credit facility with Parkview Holdings One LLC. The facility matures on April 21, 2031, and the company intends to use the proceeds for general corporate purposes.

Value
$50M
Counterparty
Parkview Holdings One LLC
Term
through April 2031
5:00 PM ET 8-K
Loan & Debt

TuHURA Biosciences $650K Debt Financing with Parkview Holdings One LLC

TuHURA Biosciences borrowed an additional $650,000 under its existing $50 million revolving credit facility with Parkview Holdings One LLC. The funds are intended for general corporate purposes, and the underlying loan agreement matures on April 21, 2031.

Value
$650K
Counterparty
Parkview Holdings One LLC
Term
through April 2031
5:01 PM ET 8-K
Loan & Debt

TuHURA Biosciences $650K Debt Financing with Parkview Holdings One LLC

TuHURA Biosciences drew down an additional $650,000 from its existing $50 million revolving credit facility with Parkview Holdings One LLC. The funds are intended for general corporate purposes, and the underlying loan agreement matures in April 2031.

Value
$650K
Counterparty
Parkview Holdings One LLC
Term
through April 21, 2031

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.